German OncoLogical Data Standard (GOLD)

.. start-badges

.. image:: https://github.com/vision-zero-oncology/GOLD/actions/workflows/fhir-validate.yml/badge.svg :target: https://github.com/vision-zero-oncology/GOLD/actions/workflows/fhir-validate.yml :alt: FSH/FHIR Validation

.. image:: https://github.com/vision-zero-oncology/GOLD/actions/workflows/ig-publish.yml/badge.svg :target: https://github.com/vision-zero-oncology/GOLD/actions/workflows/ig-publish.yml :alt: IG Publisher

Summary

Implementation guide for the German OncoLogical Data Standard (GOLD).

Publication

This Implementation Guide is published in the following locations:

• Current Build: https://vision-zero-oncology.github.io/GOLD/

Issues

Please feel free to contribute to this implementation guide. Issues and change requests are managed here:

• Issues: https://github.com/vision-zero-oncology/GOLD/issues

GOLD Implementation Group

Working Group Christof von Kalle, CSC Charité & BIH (in alphabetical order)

• Liudmila Lysyakova <https://github.com/mila-lysyakova>_
• Stefanie Rudolph

Working Group Sylvia Thun, BIH@Charité (in alphabetical order)

• Alexander Bartschke <https://github.com/Kosmos3>_
• Andrea Essenwanger <https://github.com/bytegnome>_
• Julian Saß <https://github.com/julsas>_
• Anna Trelinska-Finger, Charité CCC

Further Working Groups (in alphabetical order)

• Marc Bachmann, Novartis Pharma GmbH
• Katja Beck, MASTER Program NCT Heidelberg
• Loren Dimitrov, mint Medical GmbH
• Johannes Kast <https://github.com/johannes-kast-mint>_, mint Medical GmbH
• Simon Kreutzfeldt, MASTER Program NCT Heidelberg
• Thomas Massier, mint Medical GmbH
• Erika Schirghuber, Roche Pharma AG
• Friederike Schneider, mint Medical GmbH
• Christoph Benedikt Westphalen, CCC München LMU
• Niko Wolf, Snke OS GmbH Healthcare Plattform

Members of the Evaluation Group (in alphabetical order)

• Lars Bullinger, Charité Universitätsmedizin Berlin
• Melanie Börries, Universitätsklinikum Freiburg
• Thomas Ganslandt, Friedrich-Alexander-Universität Erlangen-Nürnberg
• Alexander Kerscher, Onkologisches Zentrum Universitätsklinikum Würzburg, CCC MF Krebsregister
• Claus R. Lattrich, Roche Pharma AG
• Patrick Metzger, Universitätsklinikum Freiburg
• Mathias Muth, Novartis Pharma GmbH
• Stefan Palm, WTZ Essen, Westdeutsches Tumorzentrum Netzwerk